Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Recording of the Earnings Conference Call held on May 30, 2024 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/GUF0220240530153526.mp3 Written transcript of the same will be submitted in due course.

pdf

Gufic BioSciences Ltd.

29 May 2024

384.50

6.49%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024 is attached herewith.

pdf

Gufic BioSciences Ltd.

21 Feb 2024

384.50

6.49%

Earnings Call

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Written Transcript of Earnings Conference Call held on February 16, 2024 at 4:30 p.m. is attached herewith.

pdf

Gufic BioSciences Ltd.

16 Feb 2024

384.50

6.49%

Earnings Call

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Recording of the Earnings Conference Call held on February 16, 2024 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/GUF0220240216151762.mp3 Written transcript of the same will be submitted in due course.

pdf

Gufic BioSciences Ltd.

14 Feb 2024

384.50

6.49%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023 is attached herewith.

pdf

Gufic BioSciences Ltd.

23 Nov 2023, 11:08AM

384.50

6.49%

Earnings Call

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The written transcript of the Earnings Conference Call held on November 17, 2023 at 04:30 PM has been uploaded on the Company''s website.

pdf

Gufic BioSciences Ltd.

17 Nov 2023

384.50

6.49%

Earnings Call

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on November 17, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_17112023.mp3 Written transcript of the same will be submitted in due course.

pdf

Gufic BioSciences Ltd.

17 Nov 2023

384.50

6.49%

Investor Presentation

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.

pdf

Gufic BioSciences Ltd.

18 Aug 2023

384.50

6.49%

Earnings Call

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

This is in continuation to our communication dated August 14, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on August 14, 2023 at 4:30 p.m., has been uploaded on the Company''s website which can be accessed through the link: http://gufic.com/Notice/WrittenTranscript_1408223.pdf

pdf

Is Gufic BioSciences Ltd. worth buying?

137 Votes:

Buy 81.75%

Sell 10.22%

Hold 8.03%

38.31% Gain from 52W Low

High volume+gain today

Gufic BioSciences Ltd. Earnings/Conference Calls

Gufic BioSciences Ltd. earnings concalls and investor presentations